TSX:HHL Holdings Information

TSX:HHL is an equity ETF with a total of 24 individual holdings. The top holdings are Eli Lilly and Company stock at 5.44%, AbbVie at 5.44%, Johnson & Johnson at 5.40%, Merck & Co. at 5.38%, and Vertex Pharmaceuticals at 5.38%.

Total Holdings

Top 10 Percentage

53.44%

Asset Class

Equity

ETF Category

Health Care

Assets

1.83B

PE Ratio

23.20

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	5.44%	62,154
2	ABBV	AbbVie Inc.	5.44%	295,969
3	JNJ	Johnson & Johnson	5.40%	290,973
4	MRK	Merck & Co., Inc.	5.38%	573,051
5	VRTX	Vertex Pharmaceuticals Incorporated	5.38%	148,195
6	AMGN	Amgen Inc.	5.33%	201,670
7	DHR	Danaher Corporation	5.30%	381,326
8	UNH	UnitedHealth Group Incorporated	5.29%	174,155
9	TMO	Thermo Fisher Scientific Inc.	5.25%	143,288
10	NVSN.MX	Novartis AG ADR	5.23%	457,045
11	A	Agilent Technologies, Inc.	5.16%	532,149
12	LON: AZN	AstraZeneca PLC	5.11%	368,895
13	SYK	Stryker Corporation	5.10%	221,792
14	ELV	Elevance Health, Inc.	5.02%	177,890
15	ABT	Abbott Laboratories	5.02%	757,820
16	BMY	Bristol-Myers Squibb Company	4.90%	1,163,684
17	MDT	Medtronic plc	4.82%	843,555
18	REGN	Regeneron Pharmaceuticals, Inc.	4.76%	104,616
19	ISRG	Intuitive Surgical, Inc.	4.30%	147,970
20	BSX	Boston Scientific Corporation	3.94%	1,264,163
21	n/a	Harvest Canadian T Bill Etp	0.44%	172,432
22	n/a	Cash And Other Net Assets And Liabilities	0.37%	n/a
23	n/a	Written Options	-1.05%	n/a
24	n/a	Foreign Currency Forwards	-1.33%	n/a

As of Jun 30, 2026